Vertex' $2.7B in CRE Value

Can you pick anyone out through the confetti? Vertex Pharmaceuticals is generating $2.7B in real estate activity at Fan Pier with the $900M, 1.1M SF build-to-suit complex that The Fallon Company started building for it in June. Add to that the lease  payments (as much as $1.8B-plus operating costs over 15 years)and it's easy to see why the summer groundbreaking looked and felt more like New Year?s Eve. The life science company's relo from its longtime Cambridge HQ has also infused confidence among other developers who have a few billion dollars more in projects in the works at the Seaport.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

Energy Company Opens 125K SF Newton Office: The Boston Deal Sheet

Simon Approaching End Of The Road With Struggling Suburban Boston Mall

Downtown Atlanta Improvement Group Picks Food Bank Chief As Next Leader

Wu Proposes Tax Breaks To Jump-Start Stalled Housing Projects

Trump's DEI Crackdown Is Creating New Risks For Landlords That Lease To The Government

Oxford Properties' U.S. Investment Head On Why It's Buying Office Again — And Where

Brandon Johnson Seeks Second Term Amid Strained CRE Relationship

Davis Looks To Sell 16-Building Beacon Hill, Back Bay Portfolio

Former CBRE Exec Suing Brokerage Giant Over Age Discrimination, Whistleblower Complaint

D.C. Investor Behind The Stacks Swaps CEO For First Time In 25 Years

Healey's New Data Center Rules Make Massachusetts A Tough Sell For Developers

Anthropic Doubling Local Presence With Cambridge Office Lease